Diagnostic Biomarkers of Prostate Cancer in 2023 and Beyond

Jeffrey J. Tosoian, MD, MPH, Assistant Professor of Urology at Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, sheds light on the critical role of cancer biomarkers and measures of clinical performance in the diagnosis of prostate cancer. Dr. Tosoian provides a thorough review of clinically-applicable literature characterizing the performance of currently-available diagnostic biomarkers for prostate cancer. He also delves into the development and validation of a novel prostate cancer biomarker that specifically targets higher-grade cancers, offering promising possibilities for improved diagnosis and treatment. This engaging presentation is a must-watch for anyone interested in the advancements and potential impact of biomarkers in the field of prostate cancer diagnosis.